(Reuters) -The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of Novo Nordisk's weight-loss drug Wegovy until a federal court ...

Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced that FDA has designated its Investigational New Drug SAP-001 as a Fast Track product for ...

ProMIS Neurosciences Granted Fast Track Designation by U.S. FDA for PMN310 in the Treatment of Alzheimer’s Disease FDA designation highlights the potential of PMN310 to deliver a more targeted ...

Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary said last month that the agency plans to remove synthetic food dyes from the U.S. food supply by revoking the authorizations of ...

Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the best mid cap growth stocks to invest in now. Earlier on June 4, Sarepta Therapeutics announced that the US FDA has granted Platform Technology ...

DualityBio, a clinical-stage biotech company dedicated to the discovery and development of next-generation ADC, announced that the US Food and Drug Administration (FDA) has granted Fast Track ...

FDA names former pharmaceutical company executive to oversee US drug program As the agency’s top drug regulator, Tidmarsh will be charged with following through on a number of commitments made ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of hereditary swelling disorder, sending its ...